Screenshot of the official website of the State Food and Drug Administration According to the official website of the State Food and drug administration, the State Food and Drug Administration recently issued a notice that after inspection, a batch of Atractylodes macrocephala and a batch of wood incense marked as produced by Hebei Quantai Pharmaceutical Co., Ltd. do not meet the requirements. Data show that Atractylodes macrocephala is a commonly used traditional Chinese medicine. Its taste is pungent, bitter and warm. Its main effect is drying dampness and strengthening the spleen. Aucklandia is a widely used traditional Chinese medicine. It is the root of Aucklandia in the composite family. It is mainly used to promote qi, relieve pain, strengthen the spleen and eliminate food. According to the notice, after inspection by Hubei Institute of drug supervision, inspection and research, a batch of Atractylodes rhizome marked as produced by Hebei Quantai Pharmaceutical Co., Ltd. does not meet the regulations, and the items that do not meet the regulations are content determination. According to the inspection of Qinghai Institute of drug inspection and testing, a batch of wood incense marked as produced by Hebei Quantai Pharmaceutical Co., Ltd. does not meet the regulations, and the items that do not meet the regulations are total ash. It is reported that content determination refers to the determination of the content of effective components in raw materials and preparations by specified test methods. The purpose of total ash determination is to detect the purity of traditional Chinese medicine. The State Food and Drug Administration said that the above drugs that do not meet the regulations are not produced by the marked enterprise after verification by the provincial drug regulatory department where the marked enterprise is located; The drug regulatory department has required relevant enterprises and units to take risk control measures such as suspension of sales and use and recall, investigate the causes of non-compliance and make practical rectification. The State Food and drug administration requires the relevant provincial drug regulatory departments to organize the investigation of the illegal acts of the above-mentioned enterprises and units suspected of producing and selling fake and inferior drugs in accordance with the drug administration law of the people's Republic of China; In the case filing and investigation, the relevant drug regulatory departments shall cooperate with each other, thoroughly investigate the source of problematic products, and disclose the investigation results according to regulations. (outlook new era)